Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients
Clinical trial NCT07709637 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07709637
- Sponsor
- LucasBio
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-31
- Primary completion
- 2026-07-31
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.